We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Udo Hoffmann

Udo Hoffmann MD, MPH

Professor of Radiology, Harvard Medical School; Chief, Division of Cardiac Imaging, Massachusetts General Hospital, Boston, Massachusetts

Dr. Hoffmann received his medical degree and doctorate from the University of Leipzig, Germany in 1995, followed by an internship in the Division of Cardiology and radiology residency at the General Hospital and University of Vienna, Austria. In 2001, Dr. Hoffmann joined the MGH Department of Radiology. After a two year fellowship in cardiovascular imaging, Dr. Hoffmann became a clinical faculty and was appointed Instructor in Radiology at Harvard Medical School in 2003. He subsequently was promoted to Assistant Professor in 2004, to Associate Professor in 2007, and to Professor in 2013. In 2006, Dr. Hoffmann graduated from the Harvard School of Public Health with a Master of Public Health. He currently serves as the Chief of the Division of Cardiac Imaging at MGH, the Director of the Cardiac MR PET CT Program, and the Director of the MGH Imaging Trial Center.

Dr. Hoffmann possesses a unique research experience in clinical trials in cardiovascular imaging, among them major NIH supported clinical trials such as ROMICAT I, ROMICAT II, PROMISE, and the imaging of the Framingham Heart Study Cohort. He leads a multidisciplinary team of >30 members with expertise in image reconstruction and assessment, teaching, epidemiology, cost effectiveness, biomarkers, and technology assessment. This research has resulted in >240 peer reviewed manuscripts, reviews and book chapters. He has national and international responsibilities to foster cardiovascular imaging, i.e. as the Co-Chair of the Imaging Oversight Committee of the Framingham Heart Study, an Associate Editor for Circulation Cardiovascular Imaging, as well as a member of the Board of Directors for the SCCT and NASCI, national initiatives, guideline committees, and task forces for the RSNA, ACR, SCAI, AHA, and ACC as well as a member of NIH review committees.